The Science Behind
Veterinary MLS® Laser Therapy
Overview: Laser Therapy
Laser Therapy, the fastest-growing modality within the veterinary market, will allow you to expand your service offerings while adding profit to your practice!
MLS Laser Therapy, a Class IV technology, provides…
- Effective treatment of painful and debilitating conditions
- Patient safety without the risk of collateral tissue damage
- A patented pulse pattern delivering unparalleled clinical results
There are many types of veterinary lasers. Each laser has different characteristics which result in a different effect. These characteristics include:
- Energy: measured in joules
- Time: Defined as the duration of irradiance of the target tissue and is measured in seconds. It is also known as Impulse Duration or called “impulse width”.
- Wavelength: Penetration depth is directed by the laser emission wavelength and the type of tissue (chromophores).
- Frequency: Defined as the number of impulses emitted during the unit of time (1 second) and should reflect the condition treated.
- Power: the rate at which energy is delivered and is measured in watts.
- Fluence: Energy Density or Dose
- Irradiance (Also known as Power Density): Power delivered per unit area
- Emission Mode: Continuous Wave (CW) or Pulsed Wave (PW)
- Impulse Duration: Duration of laser emission, also called “impulse width”.
Laser therapy uses light to favor and accelerate the body’s natural healing processes. The laser beam is moved over the skin so that the light energy (photons) penetrates the tissue where it interacts with various molecules (chromophores) that cause different biological effects. It produces a photochemical, photothermal, and photomechanical effect.
Benefits of Veterinary MLS® Laser Therapy
The innovative and patented Multiwave Locked System (MLS) Therapy Laser was developed in an effort to produce an efficient and simultaneous effect on pain, inflammation, and edema, exceeding the limits of traditional LLLT (low power) and concerns of HP (high power) laser therapy. MLS technology delivers therapeutic wavelengths, 808nm (anti-edemic and anti-inflammatory) and 905nm (analgesic), allowing a tissue penetration depth of 3-4 cm. An energetic synergy is created when delivering these wavelengths that produces greater anti-inflammatory and analgesic effects than either can produce on its own, while minimizing the risk of thermal damage. It is this unique combination and synchronization of continuous and pulsed emissions that characterizes MLS and distinguishes it from other Class IV lasers.
Unlike early-generation Class IV technology, MLS Laser Therapy has the capability to deliver controlled laser energy. This unique feature provides more accurate therapeutic dose delivery, which means consistent and repeatable results.
With high levels of efficacy, safety, and consistency, MLS Laser Therapy can help physicians relieve pain and restore lives, while rewarding their practice financially.
MLS Laser Therapy technology is the most advanced laser therapy system on the market. Reduction of response times, and therefore overall treatment times, distinguishes MLS Laser Therapy from traditional laser therapy with reciprocal advantages for both the operator and the patient.
MLS Laser Therapy allows physicians to leverage technology to provide higher quality patient care, while attracting new clients, generating additional revenue, and ultimately improving businesses’ bottom line.
Practices benefit financially by:
- Superior clinical results in both routine and specialty treatments.
- Practice differentiation by leveraging technology for better medicine.
- Short learning curve: build upon pre-existing therapy skills.
- Rapid return on investment.
- Increasing client satisfaction and referrals.
- Increase in ATP synthesis
- Increase in the production of RNA
- Increase in cellular proliferation
- Induction of differentiation processes
- Release of growth factors (fibroblasts) and other substances
- Increase in the production of molecules of the extracellular matrix (fibroblasts & condrocytes)
Low Level Laser Therapy (LLLT) Class IIIB
Safe but less effective.
High Power (HP) Class IV
Powerful but potentially dangerous.
These lasers were developed with the expectation that greater power corresponded to better efficiency. On the contrary, unless suitably controlled, high power can thermally damage the treated tissue. Therefore, the majority of high power lasers cannot operate at their maximum power without causing damage.
Multiwave Locked System (MLS) Class IV
Effective and safe.
MLS Laser Therapy is a patented emission system created to achieve an efficient and simultaneous effect on pain, contracture, inflammation, and edema within a short period of time. The patented control system that generates the MLS pulse synchronizes the emissions to achieve optimum results. Due to this characteristic synchronization, the various therapeutic effects not only take place at the same time, but reciprocally reinforce each other, without the risk of thermal damage.
Multiwave Locked System (MLS) Laser Therapy is a patented, FDA cleared technology designed to produce an efficient and simultaneous effect on pain, contracture, inflammation, and edema within a short period of time. The control system that generates the MLS pulse synchronizes the emissions to achieve optimum results. Due to this unique synchronization, the various therapeutic effects not only take place at the same time, but reciprocally reinforce each other, without the risk of thermal damage.
MLS Laser Therapy has been cleared for the temporary relief of muscle and joint pain and stiffness, arthritis pain, or muscle spasm. It has been reported that pain associated with arthritis, tendonitis, wounds, post-surgical swelling, inflamed ears, lick granuloma, hip dysplasia, disc disease, lameness, sinusitis and other conditions have been effectively treated with MLS.
MLS Laser Therapy uses both the 808nm and 905nm wavelengths simultaneously. The 808nm wavelength is delivered using continuous emission while the 905nm wavelength is delivered using pulsed emission. Additionally, a 635nm wavelength is emitted to highlight the target area.
MLS Laser Therapy uses two wavelengths to overcome the limits of traditional Laser Therapy. Traditional Laser therapy does not deliver both wavelengths in a reinforcing and synchronized fashion. Continuous laser emissions act fast on inflammation, stimulating blood and lymphatic circulation and inducing fast re-absorption of fluid build ups; however they only have a secondary effect on pain, which is diminished after reducing the inflammatory process. Pulsed laser emissions, on the other hand, have a practically immediate effect on pain, since they are able to induce analgesia, interfering with the very transmission of the pain impulse to the higher brain centers, but they are less effective at treating inflammation and edema.
The FDA has cleared the use of MLS Laser Therapy and it is also patented via the U.S. Patent Office.
MLS Laser Therapy is able to induce strong anti-inflammatory, anti-edema, and analgesic effects simultaneously and within a short period of time. LLLT cannot achieve these results because of the limitations of using one or two wavelengths that are not synchronized. The patented control system that generates the MLS pulse synchronizes the emissions to achieve results previously unattainable. Thanks to this characteristic synchronization, the various therapeutic effects not only take place at the same time but reciprocally reinforce each other.
MLS Stands for Multiwave Locked System. MLS is the name of the technology used that utilizes the patented combination of wavelengths.
Yes, MLS Lasers are Class IV lasers with a peak power of 75 watts.
The depth of penetration varies due to tissue type, but it will penetrate 3-5 cm in most cases.
Results can often been seen after the first treatment. Most conditions have protocols that range from 6-12 treatments. The treatments are cumulative and are delivered 2-3 times per week for 2-3 weeks.
MLS Laser Therapy has been developed and tested following a strict course of biomedical and clinical research. The effectiveness of the combination of the emissions making up the MLS pulse was initially tested in vitro on cellular cultures, then in vivo on animals, and finally by means of controlled clinical trials run by major state-of-the-art health organizations for treating traumatic and degenerative painful diseases.